Catalyst Pharmaceuticals Inc Cash Flow-to-Debt Ratio
Catalyst Pharmaceuticals Inc cash flow-to-debt ratio. Catalyst Pharmaceuticals Inc (CPRX) has a Cash Flow-to-Debt Ratio of 0.44x as of March 2026, meaning its operating cash flow of $59.59 Million could theoretically repay 0% of its total liabilities ($134.91 Million) in one year. Check cash flow quality index of Catalyst Pharmaceuticals Inc to evaluate the quality of earnings relative to operating cash generation.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Catalyst Pharmaceuticals Inc (2004–2025)
Cash flow-to-debt ratio of Catalyst Pharmaceuticals Inc from 2004 to 2025. Historical debt coverage capacity for Catalyst Pharmaceuticals Inc across 22 annual periods. Check CPRX cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Catalyst Pharmaceuticals Inc Cash Flow-to-Debt Ratio by Year (2004–2025)
Catalyst Pharmaceuticals Inc cash flow-to-debt ratio by year from 2004 to 2025. Year-by-year debt coverage analysis for Catalyst Pharmaceuticals Inc. For the full cash flow conversion analysis, see CPRX cash generation efficiency.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 1.37x | $208.67 Million | $152.54 Million | ▼ -29.4% |
| 2024 | 1.94x | $239.81 Million | $123.78 Million | ▲ +10.9% |
| 2023 | 1.75x | $143.60 Million | $82.23 Million | ▲ +13.2% |
| 2022 | 1.54x | $116.05 Million | $75.21 Million | ▼ -20.9% |
| 2021 | 1.95x | $60.37 Million | $30.96 Million | ▼ -1.5% |
| 2020 | 1.98x | $45.03 Million | $22.76 Million | ▲ +41.5% |
| 2019 | 1.40x | $34.61 Million | $24.75 Million | ▲ +152.6% |
| 2018 | -2.66x | $-25.70 Million | $9.67 Million | ▲ +14.4% |
| 2017 | -3.11x | $-13.74 Million | $4.42 Million | ▲ +58.5% |
| 2016 | -7.49x | $-17.96 Million | $2.40 Million | ▼ -92.3% |
| 2015 | -3.89x | $-18.02 Million | $4.63 Million | ▼ -160.8% |
| 2014 | -1.49x | $-12.94 Million | $8.67 Million | ▲ +39.8% |
| 2013 | -2.48x | $-9.88 Million | $3.98 Million | ▼ -4.7% |
| 2012 | -2.37x | $-5.14 Million | $2.17 Million | ▼ -18.4% |
| 2011 | -2.00x | $-4.99 Million | $2.49 Million | ▲ +83.3% |
| 2010 | -11.98x | $-3.76 Million | $313.71K | ▲ +45.7% |
| 2009 | -22.05x | $-7.68 Million | $348.52K | ▼ -293.0% |
| 2008 | -5.61x | $-8.26 Million | $1.47 Million | ▲ +54.7% |
| 2007 | -12.39x | $-4.42 Million | $357.17K | ▼ -712.4% |
| 2006 | -1.52x | $-1.18 Million | $772.85K | ▼ -14.9% |
| 2005 | -1.33x | $-455.36K | $342.99K | ▲ +61.0% |
| 2004 | -3.40x | $-230.52K | $67.80K | — |